Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
The debate over maternal mortality data risks overshadowing the need to improve care for new moms, experts say.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
President-elect Trump and Elon Musk killed the funding bill, taking the health policies with it.
Andrea Miyahira interviews Cornelia (Chien-Kuang) Ding about her study on predicting prostate cancer grade reclassification using a deep learning-based grading algorithm. Dr. Ding discusses their…
A new report from the Government Accountability Office offered policy suggestions for Congress and federal agencies to make brain-computer interfaces a reality for patients.
David McConkey discusses the application of artificial intelligence (AI) in bladder cancer research, focusing on AI pathology. He outlines ongoing collaborations between cooperative groups and…
James Mannion knew what he needed. For nine months, while incarcerated in a county jail in Portland, Maine, he pleaded for a medication called
The updated definition allows more food to qualify as healthy, including higher fat fish, nuts, seeds, and certain oils.